Lili Yu

3.7k total citations · 1 hit paper
123 papers, 2.5k citations indexed

About

Lili Yu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Lili Yu has authored 123 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Molecular Biology, 21 papers in Oncology and 18 papers in Cancer Research. Recurrent topics in Lili Yu's work include Epigenetics and DNA Methylation (13 papers), RNA modifications and cancer (9 papers) and Cancer-related molecular mechanisms research (8 papers). Lili Yu is often cited by papers focused on Epigenetics and DNA Methylation (13 papers), RNA modifications and cancer (9 papers) and Cancer-related molecular mechanisms research (8 papers). Lili Yu collaborates with scholars based in China, Macao and United States. Lili Yu's co-authors include Zehua Wang, Jing Cai, Weimin Huang, Wancheng Chen, Qibiao Wu, Ziyuan Lu, Yukai Huang, Yang Xu, Hongbo Li and Zenghui Liu and has published in prestigious journals such as Nature Communications, PLoS ONE and Oncogene.

In The Last Decade

Lili Yu

116 papers receiving 2.5k citations

Hit Papers

Selective utilization of medicinal polysaccharides by hum... 2025 2026 2025 5 10 15 20 25

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lili Yu China 28 1.2k 549 359 357 335 123 2.5k
Yongli Guo China 26 1.1k 0.9× 577 1.1× 353 1.0× 518 1.5× 129 0.4× 122 2.4k
Wei He China 31 1.3k 1.1× 716 1.3× 421 1.2× 368 1.0× 160 0.5× 188 3.0k
Jun Yang China 28 1.2k 1.0× 548 1.0× 462 1.3× 364 1.0× 128 0.4× 134 2.6k
Ali S. Alzahrani Saudi Arabia 33 1.3k 1.1× 585 1.1× 567 1.6× 618 1.7× 321 1.0× 155 3.4k
Yang Shen China 28 1.9k 1.6× 498 0.9× 221 0.6× 406 1.1× 273 0.8× 115 3.3k
Lei Yu China 27 990 0.8× 630 1.1× 372 1.0× 273 0.8× 328 1.0× 140 2.4k
Haleh Akhavan‐Niaki Iran 27 1.4k 1.2× 522 1.0× 189 0.5× 285 0.8× 171 0.5× 118 2.8k
Weifeng Shen China 27 1.2k 1.0× 461 0.8× 662 1.8× 347 1.0× 267 0.8× 109 2.9k
Jie Xiong China 29 1.4k 1.1× 690 1.3× 286 0.8× 562 1.6× 153 0.5× 128 3.2k
Hui Huang China 28 870 0.7× 271 0.5× 340 0.9× 316 0.9× 260 0.8× 187 2.7k

Countries citing papers authored by Lili Yu

Since Specialization
Citations

This map shows the geographic impact of Lili Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lili Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lili Yu more than expected).

Fields of papers citing papers by Lili Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lili Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lili Yu. The network helps show where Lili Yu may publish in the future.

Co-authorship network of co-authors of Lili Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Lili Yu. A scholar is included among the top collaborators of Lili Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lili Yu. Lili Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Shubo, Ziming Zhao, Lili Yu, et al.. (2025). Identification of Quercetin as a Natural MMP1 Inhibitor for Overcoming Cisplatin Resistance in Epithelial Ovarian Cancer. Journal of Cancer. 16(8). 2578–2594.
2.
Qu, Zepeng, Hongbin Liu, Jumin Huang, et al.. (2025). Selective utilization of medicinal polysaccharides by human gut Bacteroides and Parabacteroides species. Nature Communications. 16(1). 638–638. 25 indexed citations breakdown →
3.
Yan, Peiyu, et al.. (2025). Efficacy of Auricular Therapy for Motor Impairment After Stroke: A Systematic Review and Meta‐Analysis. International Journal of Older People Nursing. 20(1). e70006–e70006.
4.
Yu, Lili, et al.. (2025). Effect of Smoking on Mortality in Individuals With COPD in the United States. Respiratory Care. 70(5). 559–565.
6.
Wang, Yufei, Naveed Ahmad, Lili Yu, et al.. (2024). CtDREB52 transcription factor regulates UV-B-induced flavonoid biosynthesis by transactivating CtMYB and CtF3′H in Safflower (Carthamus tinctorius L.). Plant Stress. 11. 100384–100384. 6 indexed citations
7.
Tian, Ruimin, Shan Guo, Shudong Chen, et al.. (2024). Natural products as Nrf2 modulators for ferroptosis inhibition in renal disease therapy: Recent progress and future prospects. Phytomedicine. 136. 156342–156342. 7 indexed citations
8.
Wang, Lijuan, Ying Lü, Doudou Li, et al.. (2024). The landscape of the methodology in drug repurposing using human genomic data: a systematic review. Briefings in Bioinformatics. 25(2). 7 indexed citations
9.
Sun, Yuhao, Shuai Yuan, Xuejie Chen, et al.. (2023). The Contribution of Genetic Risk and Lifestyle Factors in the Development of Adult-Onset Inflammatory Bowel Disease: A Prospective Cohort Study. The American Journal of Gastroenterology. 118(3). 511–522. 62 indexed citations
10.
Zhou, Xuan, Qian Xiao, Fangyuan Jiang, et al.. (2023). Dissecting the pathogenic effects of smoking and its hallmarks in blood DNA methylation on colorectal cancer risk. British Journal of Cancer. 129(8). 1306–1313. 14 indexed citations
11.
Xu, Youhua, et al.. (2023). Shuangdan Mingmu Capsule for Diabetic Retinopathy: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials. Evidence-based Complementary and Alternative Medicine. 2023(1). 4655109–4655109. 1 indexed citations
12.
Jiang, Fangyuan, Daniel Boakye, Jing Sun, et al.. (2023). Association between antibiotic use during early life and early‐onset colorectal cancer risk overall and according to polygenic risk and FUT2 genotypes. International Journal of Cancer. 153(9). 1602–1611. 16 indexed citations
13.
Yu, Lili, Rong Wang, Nana Wang, et al.. (2023). Chemical Synthesis, Safety and Efficacy of Antihypertensive Candidate Drug 221s (2,9). Molecules. 28(13). 4975–4975. 3 indexed citations
15.
Zhou, Xuan, Lili Yu, Lijuan Wang, et al.. (2022). Alcohol consumption, blood DNA methylation and breast cancer: a Mendelian randomisation study. European Journal of Epidemiology. 37(7). 701–712. 17 indexed citations
16.
Wang, Lijuan, Xiaomeng Zhang, Xiangrui Meng, et al.. (2021). Methodology in phenome-wide association studies: a systematic review. Journal of Medical Genetics. 58(11). 720–728. 14 indexed citations
17.
Yu, Lili, et al.. (2017). Primary pancreatic lymphoma: two case reports and a literature review. OncoTargets and Therapy. Volume 10. 1687–1694. 15 indexed citations
18.
Huang, Weimin, et al.. (2017). Posterior Lumbar Interbody Fusion with Interspinous Fastener Provides Comparable Clinical Outcome and Fusion Rate to Pedicle Screws. Orthopaedic Surgery. 9(2). 198–205. 5 indexed citations
19.
Cao, Nan, Jing Liao, Zumei Liu, et al.. (2011). In vitro differentiation of rat embryonic stem cells into functional cardiomyocytes. Cell Research. 21(9). 1316–1331. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026